Erratum: Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions (Scientific Reports (2012) 2 (0529) DOI: 10.1038/srep00529);Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Ishigaki, Shinsuke ^a,c   Masuda, Akio ^a   Fujioka, Yusuke ^a   Iguchi, Yohei ^a   Katsuno, Masahisa ^a   Shibata, Akihide ^a   Urano, Fumihiko ^b   Sobue, Gen ^a,c   Ohno, Kinji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; RNA BINDING PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL; ARTICLE; CEREBELLUM CORTEX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOTONEURON; MOUSE; PROMOTER REGION; PROTEIN BINDING;

ALTERNATIVE SPLICING; ANIMALS; CEREBELLAR CORTEX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; MICE; MOLECULAR SEQUENCE ANNOTATION; MOTOR NEURONS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA; RNA-BINDING PROTEIN FUS; TRANSCRIPTION, GENETIC;

EID: 84864448921     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03301     Document Type: Erratum

References (42)

1. Strong, M. J. & Volkening, K. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis? FEBS J 278, 3569-3577 (2011).
2. Lagier-Tourenne, C. & Cleveland, D. W. Rethinking ALS: The FUS about TDP-43. Cell 136, 1001-1004 (2009).
3. Kwiatkowski, T. J., Jr. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208 (2009).
4. Vance, C. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211 (2009).
5. Deng, H. X. et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67, 739-748 (2010).
6. Bosco, D. A. et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19, 4160-4175 (2010).
7. Dormann, D. et al. ALS-Associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29, 2841-2857 (2010).
8. Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H. & Suzuki, N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol 69, 152-162 (2011).
9. Kino, Y. et al. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res 39, 2781-2798 (2011).
10. Wang, X. et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454, 126-130 (2008).
11. Kabashi, E. et al. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet 7, e1002214 (2011).
12. Guipaud, O. et al. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins. Proteomics 6, 5962-5972 (2006).
13. Bertolotti, A., Lutz, Y., Heard, D. J., Chambon, P. & Tora, L. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 15, 5022-5031 (1996).
14. Meissner, M., Lopato, S., Gotzmann, J., Sauermann, G. & Barta, A. Protooncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp Cell Res 283, 184-195 (2003).
15. Yang, L., Embree, L. J., Tsai, S. & Hickstein, D. D. Oncoprotein TLS interacts with serine-Arginine proteins involved in RNA splicing. J Biol Chem 273, 27761-27764 (1998).
16. Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464-469 (2008).
17. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57 (2009).
18. Dennis, G., Jr. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3 (2003).
19. Hoell, J. I. et al. RNA targets of wild-Type and mutant FET family proteins. Nat Struct Mol Biol 18, 1428-1431 (2011).
20. Liu, X., Brutlag, D. L. & Liu, J. S. BioProspector: discovering conserved DNA motifs in upstream regulatory regions of co-expressed genes. Pac Symp Biocomput 127-138 (2001).
21. Bailey, T. L. & Elkan, C. The value of prior knowledge in discovering motifs with MEME. Proc Int Conf Intell Syst Mol Biol 3, 21-29 (1995).
22. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31, 3406-3415 (2003).
23. Xue, Y. et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor tomodulate exon inclusion or skipping. Mol Cell 36, 996-1006 (2009).
24. Masuda, A. et al. CUGBP1 and MBNL1 preferentially bind to 39 UTRs and facilitate mRNA decay. Sci Rep 2, 209 (2012).
25. Colombrita, C. et al. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-Transcriptional fate in motoneuron-like cells. J Biol Chem Epub (2012).
26. Lerga, A. et al. Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 276, 6807-6816 (2001).
27. Iko, Y. et al. Domain architectures and characterization of an RNA-binding protein, TLS. J Biol Chem 279, 44834-44840 (2004).
28. Fujii, R. & Takumi, T. TLS facilitates transport of mRNA encoding an actinstabilizing protein to dendritic spines. J Cell Sci 118, 5755-5765 (2005).
29. Core, L. J., Waterfall, J. J. & Lis, J. T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322, 1845-1848 (2008).
30. Seila, A. C. et al. Divergent transcription from active promoters. Science 322, 1849-1851 (2008).
31. Tan, A. Y., Riley, T. R., Coady, T., Bussemaker, H. J. & Manley, J. L. TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elements. Proc Natl Acad Sci U S A Epub (2012).
32. Lagier-Tourenne, C., Polymenidou, M.&Cleveland, D. W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19, R46-64 (2010).
33. van Blitterswijk, M. & Landers, J. E. RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics 11, 275-290 (2010).
34. Hong, M. et al.Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917 (1998).
35. Yoshida, M. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 26, 457-470 (2006).
36. Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268 (2011).
37. DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256 (2011).
38. Ranum, L. P. & Cooper, T. A. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29, 259-277 (2006).
39. Moseley, M. L. et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 38, 758-769 (2006).
40. Rudnicki, D. D. et al. Huntington's disease-like 2 is associated with CUG repeatcontaining RNA foci. Ann Neurol 61, 272-282 (2007).
41. Campeau, E. et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 4, e6529 (2009).
42. Quinlan, A. R. & Hall, I. M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).